Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Clin Geriatr Med. 2013 Nov;29(4):809–828. doi: 10.1016/j.cger.2013.07.006

Table 4.

Emerging Biomarkers

Purpose Biomarker
Marker of amyloid pathology in AD Plasma 42
Marker of synapse dysfunction and neurodegeneration in AD CSF VILIP-1
Hydrogen 1 MR spectroscopy
Functional MRI
Diffusion tensor imaging
Magnetic resonance perfusion
Marker of oxidative stress and inflammation CSF Isoprostane
CSF interleukins and growth factors
CSF S-100B and GFAP
CSF YKL-40
Lipidomics Serum ceramides
Marker of Non-AD process CSF α-synuclein
CSF neurofilament
CSF TDP-43